D.E. Shaw & Co’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-38,566
| Closed | -$99.1K | – | 3371 |
|
|
2024
Q2 | $99.1K | Sell |
38,566
-31,936
| -45% | -$82.1K | ﹤0.01% | 2899 |
|
|
2024
Q1 | $206K | Buy |
70,502
+11,432
| +19% | +$33.4K | ﹤0.01% | 2746 |
|
|
2023
Q4 | $136K | Buy |
+59,070
| New | +$136K | ﹤0.01% | 2734 |
|
|
2022
Q2 | – | Sell |
-13,744
| Closed | -$119K | – | 4359 |
|
|
2022
Q1 | $119K | Sell |
13,744
-161,051
| -92% | -$1.39M | ﹤0.01% | 3726 |
|
|
2021
Q4 | $2.5M | Buy |
+174,795
| New | +$2.5M | ﹤0.01% | 2238 |
|
|
2015
Q1 | – | Sell |
-27,708
| Closed | -$126K | – | 2623 |
|
|
2014
Q4 | $126K | Buy |
27,708
+10,705
| +63% | +$48.7K | ﹤0.01% | 2385 |
|
|
2014
Q3 | $137K | Sell |
17,003
-5,041
| -23% | -$40.6K | ﹤0.01% | 2248 |
|
|
2014
Q2 | $212K | Buy |
+22,044
| New | +$212K | ﹤0.01% | 2168 |
|